Table 4 Partial Least Square analysis (PLS); the association between tumor characteristics and lipoprotein subfractions by NMR
Tumor Characteristic | β-coefficient | p-value |
|---|---|---|
Progesterone receptor, % | ||
 Total plasma Apolipoprotein A1, mg/dL | 1.326 e-01 | 0.002 |
 ILDL Free Cholesterol, mg/dL | −6.625 e-03 | 0.062 |
 ILDL Phospholipids, mg/dL | −1.015 e-02 | 0.076 |
 HDL Cholesterol, mg/dL | 9.019 e-02 | 8.522 e-06 |
 HDL Free Cholesterol, mg/dL | 1.918 e-02 | 0.002 |
 HDL Phospholipids, mg/dL | 1.206 e-01 | 1.138 e-04 |
 HDL Apolipoprotein A1, mg/dL | 1.393 e-01 | 1.198 e-04 |
 VLDL4 Cholesterol, mg/dL | −1.227 e-02 | 0.068 |
 VLDL4 Free Cholesterol, mg/dL | −5.829 e-03 | 0.085 |
 VLDL4 Phospholipids, mg/dL | −1.138 e-02 | 0.056 |
 HDL1 Cholesterol, mg/dL | 4.957 e-02 | 0.014 |
 HDL1 Phospholipids, mg/dL | 6.670 e-02 | 0.012 |
 HDL1 Apolipoprotein A1, mg/dL | 7.637 e-02 | 0.022 |
 HDL1 Apolipoprotein A2, mg/dL | 7.235 e-03 | 0.041 |
 HDL2 Free Cholesterol, mg/dL | 3.600 e-03 | 0.040 |
 HDL2 Phospholipids, mg/dL | 2.240 e-02 | 0.009 |
 HDL2 Apolipoprotein A1, mg/dL | 2.479 e-02 | 0.012 |
 HDL3 Phospholipids, mg/dL | 2.549 e-02 | 0.011 |
 HDL3 Apolipoprotein A1, mg/dL | 2.906 e-02 | 0.016 |
Tumor grade 1–3 | ||
 Total plasma Triglycerides, mg/dL | −2.694 e-03 | 0.011 |
 HDL Apolipoprotein A1, mg/dL | −1.807 e-03 | 0.056 |
Ki67 % | ||
 HDL Cholesterol, mg/dL | −3.252 e-02 | 0.060 |
 HDL2 Cholesterol, mg/dL | −7.904 e-03 | 0.083 |
Estrogen receptor, % | No significant results | |
Nodal metastasis, no | ||